FDA recommends booster dose of Johnson & Johnson vaccine

FDA recommends booster dose of Johnson & Johnson vaccine
FDA recommends booster dose of Johnson & Johnson vaccine

The US Food and Drug Administration’s advisory committee voted unanimously to recommend a booster dose of the Johnson & Johnson vaccine no less than two months after a person received the first dose.

On Friday, Johnson & Johnson announced that the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted unanimously by 19 votes and no opposition to grant emergency use authorization for its anti-coronavirus vaccine to adults 18 years of age and older after at least Two months after taking a single dose of the vaccine.

The committee’s decision was based on the results of the third phase of trials, which showed that a booster dose increased protection to 94% against moderate and severe/critical cases of Covid-19 in the United States.
“Today’s recommendation is based on the body of evidence, with clinical and factual data showing that while a single dose provides strong, long-term protection against Covid-19, giving a booster dose After the basic single-dose vaccination increases protection, especially against the symptoms of COVID-19.

Source

FDA recommends booster dose Johnson Johnson vaccine

 
For Latest Updates Follow us on Google News
 

PREV Five sensitive tasks that Xavi must address in Barcelona
NEXT ATM cash withdrawals drop 5% in the third quarter